Frequently asked questions

Yes, it does. Our height supplement was designed & developed based on hundreds of medical studies to find the active ingredients to naturally support your body to achieve its genetic potential height.

NuBest Tall works for children and teenagers at the ages from 5 to 20. It is especially effective during puberty (10-14 years old). Generally, human growth plates after the age of 20 will be closed. Once the growth plates are closed, people will not be able to grow taller naturally.

Results may vary from person to person. Normally, it will take at least 6 months of continuous use to see clear results (changes and difference in height).

At puberty (10-14 years old), children will increase by 4-6 inches per year on average. After puberty, children will increase by 1-2 inches per year on average.

NuBest Tall is created by special and exclusive ingredients combining Calicum, Hydrolyzed Collagen and many rare and precious herbs that stimulate the pituitary gland to promote healthy bone growth, thereby it can support children to achieve their expected height naturally and safely.

To explain how NuBest Tall works, I’ll use an analogy. If you have a plant and you water it and give it sunlight, it will grow. However, if you have that same plant and you water it, give it sunlight and also give it plant foods, it will grow more because it has more of what it needs in order to grow. NuBest Tall works the same way with your bones, it gives them everything they need in order to unleash their growth.

NuBest Tall has been supporting people to meet their height goals since 2009. There have not been any reports of side effects.

Because of the difference in each person, we recommend consulting your pharmacist or doctor before taking any supplement.

NuBest Tall is a height growth supplement that has a combination between the quintessence of Eastern practices and the accuracy and advancement of Western practices. NuBest Tall contains 7 precious herbs that stimulate the pituitary gland to promote healthy bone growth, thereby increasing height naturally and safely.

Made in the USA in an FDA-Registered facility. This product is cGMP-certified and HACCP-certified  to assure high quality and purity. NATURAL & NON-GMO - Gluten free, dairy free, soy free, no antibiotics, no preservatives, no yeast, no soy, no sugar, no cholesterol, no artificial colors/flavors, no binders.

100% MONEY-BACK GUARANTEE in case of 6 months using without any effect (applicable to people under 18 years old), before and after photo proof needed and papers showing age of user.

The suggested doses are:

- One (1) capsule twice daily about 30 minutes before meals for 5 - 9 years old people

- One (1) capsule three times daily about 30 minutes before meals for 10 - 20 years old people.

(*) If children cannot swallow the capsule, you can open up the capsule and mix the powder with water, milk, juice, smoothie or liquid foods such as porridge or soup.

NuBest Tall should be continuously used for a period of at least 6 months to get the result. After every 6 months of continuous use, the users can pause for 1 month and then continue to use again.

(*) Children and teenagers can use NuBest Tall until their growth plates are closed to get maximum height.


  • Allen, D. (2013). Short Stature in Childhood — Challenges and Choices. The New England Journal of Medicine, 368(13), 1220-1228.
  • Al-Uzri, A., Matheson, M., Gipson, D., Mendley, S., Hooper, S., Yadin, O., . . . Gerson, A. (2013). The impact of short stature on health-related quality of life in children with chronic kidney disease. The Journal of Pediatrics, 163(3), 736-41.e1.
  • Amato, R., Miele, G., Monticelli, A., Cocozza, S., & Mailund, T. (2011). Signs of Selective Pressure on Genetic Variants Affecting Human Height (Signs of Selection on Human Height). PLoS ONE, 6(11), E27588.
  • Baik, M., Yu, J., & Hennighausen, L. (2011). Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism. Annals of the New York Academy of Sciences, 1229(1), 29-37.
  • Bengtsson, B. (1999). Growth Hormone (Endocrine Updates, 4).
  • Bentham, J. (2016). A century of trends in adult human height. ELife, 5(2016JULY), 1-29.
  • Cameron, N., & Bogin, Barry. (2014). Human Growth and Development (2nd ed.). New York: Elsevier Science.
  • Case, A., Paxson, C., 2006. Stature and Status: Height, Ability, and Labor Market Outcomes. NBER Working Paper No. 12466.
  • Cuttler, L., & Rosenfield, R. (2011). Assessing the value of treatments to increase height. The New England Journal of Medicine, 364(13), 1274-6.
  • Daniel F Gudbjartsson, G Bragi Walters, Gudmar Thorleifsson, Hreinn Stefansson, Bjarni V Halldorsson, Pasha Zusmanovich, . . . Kari Stefansson. (2008). Many sequence variants affecting diversity of adult human height. Nature Genetics, 40(5), 609-615.
  • Dasgupta, P., & Hauspie, Roland. (2001). Perspectives in Human Growth, Development and Maturation.
  • Davies, J., & Cheetham, T. (2014). Investigation and management of tall stature. Archives Of Disease In Childhood, 99(8), 772-777.
  • Deboer, M., Agard, H., & Scharf, R. (2015). Milk intake, height and body mass index in preschool children. Archives Of Disease In Childhood, 100(5), 460-465.
  • Denis, Brambati, Dessauvages, Guedj, Ridoux, Meffre, & Autier. (2008). Molecular weight determination of hydrolyzed collagens. Food Hydrocolloids, 22(6), 989-994.
  • Deodati, A., & Cianfarani, S. (2011). Impact of growth hormone therapy on adult height of children with idiopathic short stature: Systematic review. BMJ, 342(7798), 636.
  • Dumont-Driscoll, M., Dannemiller Memorial Educational Foundation, Resource Group, Pfizer Inc, & Symposium on the Appropriate Use of Growth Hormone in Pediatric Patients. (2005). Evidence based decision making the appropriate use of growth hormone in pediatric patients. United States]: [s.n.].
  • Giustina, A., & Manelli, Filippo. (2001). Growth Hormone And The Heart (1.. ed., Endocrine Updates, 9).
  • Gordon, Catherine. "Prevalence of Vitamin D Deficiency." Archive of Pediatric & Adolescent Medicine (2004).
  • Grimm, Kevin J., Ram, Nilam, & Hamagami, Fumiaki. (2011). Nonlinear Growth Curves in Developmental Research. Child Development, 82(5), 1357-1371.
  • Jian Yang, Andrew Bakshi, Zhihong Zhu, Gibran Hemani, Anna A E Vinkhuyzen, Sang Hong Lee, . . . Peter M Visscher. (2015). Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nature Genetics, 47(10), 1114-11120.
  • Kanalay, Growth Hormone, Arginine, & Exercise. Current opinion clinical nutrition metabolic journal. 2008
  • Laurie E. Cohen. (2014). Idiopathic short stature: A clinical review. JAMA, The Journal of the American Medical Association, 311(17), 1787-1796.
  • Lello, L., Avery, S., Tellier, L., Vazquez, A., De Los Campos, G., & Hsu, S. (2018). Accurate Genomic Prediction of Human Height. Genetics, 210(2), 477-497.
  • M Preising, A Suchomlinov, J Tutkuviene, & C Aßmann. (2016). Modelling human height and weight: A Bayesian approach towards model comparison. European Journal of Clinical Nutrition, 70(6), 656-661.
  • National Institue of Arthritis and Musculoskeletal and Skin Disease, "Juvenile Bone Health: Kids and Their Bones: A Guide for Parents." National Institue of Health (2009).
  • National Institute for Clinical Excellence, & Great Britain. National Health Service. (2002). Guidance on the use of human growth hormone (somatropin) in children with growth failure (Technology appraisal guidance ; no. 42). London: National Institute for Clinical Excellence.
  • Nelson, Saleheen, Hopewell, Hamby, Zeng, Assimes, . . . Samani. (2015). Genetically determined height and coronary artery disease. 372(17), 1608.
  • Papadimitriou, A, Douros, K, Papadimitriou, Dt, Kleanthous, K, Karapanou, O, & Fretzayas, A. (2012). Characteristics of the short children referred to an academic paediatric endocrine clinic in Greece. Journal Of Paediatrics And Child Health, 48(3), 263-267.
  • Perola, M. (2011). Genome-wide association approaches for identifying loci for human height genes. Best Practice & Research Clinical Endocrinology & Metabolism, 25(1), 19-23.
  • Porta, M., & Last, J. (2018). Growth hormone. A Dictionary of Public Health, A Dictionary of Public Health.
  • Preedy, V. (2012). Handbook of Growth and Growth Monitoring in Health and Disease.
  • Prentice, Ann, Dibba, Bakary, Sawo, Yankuba, & Cole, Tim J. (2012). The effect of prepubertal calcium carbonate supplementation on the age of peak height velocity in Gambian adolescents.(Report)(Author abstract). American Journal of Clinical Nutrition, 96(5), 1042.
  • Pryce, J., Hayes, B., Bolormaa, S., & Goddard, M. (2011). Polymorphic regions affecting human height also control stature in cattle. Genetics, 187(3), 981-4.
  • Ross, J., Czernichow, P., Biller, B., Colao, A., Reiter, E., & Kiess, W. (2010). Growth hormone: Health considerations beyond height gain. Pediatrics, 125(4), E906-18.
  • Shin, D., Oh, C., Kim, Y., & Hwang, Y. (2012). Ancient-to-modern secular changes in Korean stature. American Journal of Physical Anthropology, 147(3), 433-42.
  • Silvers, J., Marinova, D., Mercer, M., Connors, A., & Cuttler, L. (2010). A National Study of Physician Recommendations to Initiate and Discontinue Growth Hormone for Short Stature. Pediatrics, 126(3), 468-476.
  • Stulp, G., & Barrett, L. (2016). Evolutionary perspectives on human height variation. 91(1), 206-234.
  • Stulp, G., Verhulst, S., Pollet, T., Nettle, D., & Buunk, A. (2011). Parental Height Differences Predict the Need for an Emergency Caesarean Section. Plos One, 6(6), E20497.
  • Tambs, K., Sundet, J., & Eriksen, W. (2013). Adult body height of twins compared with that of singletons: A register-based birth cohort study of norwegian males. American Journal of Epidemiology, 177(9), 1015.
  • Topor, L., Feldman, H., Bauchner, H., & Cohen, L. (2010). Variation in Methods of Predicting Adult Height for Children With Idiopathic Short Stature. Pediatrics, 126(5), 938-944.
  • Wang, Y., Zhang, H., Cao, M., Kong, L., & Ge, X. (2019). Analysis of the value and correlation of IGF-1 with GH and IGFBP-3 in the diagnosis of dwarfism. Experimental and Therapeutic Medicine, 17(5), 3689-3693.
  • Whiting, Susan. "Factors that Affect Bone Mineral Accrual in the Adolescent Growth Spurt." The Journal of Nutrition 134:696S-700S(2004).